Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Color Diagnostics, |
RCV000581958 | SCV000689660 | uncertain significance | Hereditary cancer-predisposing syndrome | 2018-09-02 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001853917 | SCV002141767 | uncertain significance | Familial cancer of breast | 2023-05-18 | criteria provided, single submitter | clinical testing | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may create or strengthen a splice site. ClinVar contains an entry for this variant (Variation ID: 491601). This variant has not been reported in the literature in individuals affected with CHEK2-related conditions. This variant is present in population databases (no rsID available, gnomAD 0.009%). This sequence change falls in intron 13 of the CHEK2 gene. It does not directly change the encoded amino acid sequence of the CHEK2 protein. |
Baylor Genetics | RCV001853917 | SCV005058431 | uncertain significance | Familial cancer of breast | 2023-11-09 | criteria provided, single submitter | clinical testing |